Evidence map›Paper›PMID 19917672›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2010

Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-{gamma}/JAK/STAT1 signaling is critical for the expression of PTN in macrophages.

Fuqiang Li, Fang Tian, Lai Wang, Ian K Williamson, Behrooz G Sharifi, Prediman K Shah

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Pleiotrophin drives a prometastatic immune niche in breast cancer.The Journal of experimental medicine · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Circulating Proteomic Signatures of Chronological Age.The journals of gerontology. Series A, Biological sciences and medical sciences · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fuqiang LiCedars-Sinai Medical Center, Davis Bldg. 1016, 8700 Beverly Blvd., Los Angeles, CA 90048, USA.
Fang Tian
Lai Wang
Ian K Williamson
Behrooz G Sharifi
Prediman K Shah
Cedars-Sinai Medical Center · US

Funding

The Role of Tenascin in Neointimal FormationR01HL050566 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI SHAH, PREDIMAN KRISHAN · 2000 to 2009
$2.7M
PTN FUNCTION IN INTIMAL THICKENINGR01HL104068 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI SHAH, PREDIMAN KRISHAN · 2011 to 2014
$1.6M
Directed Vascular Graft Regeneration in the Mouse Peritoneal CavityR01HL090653 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI SHAH, PREDIMAN KRISHAN, SHARIFI, BEHROOZ G · 2008 to 2011
$1.6M
NHLBI NIH HHS R01 HL050566NHLBI NIH HHS R01 HL090653NHLBI NIH HHS R01 HL104068
6 · The paper itself

Abstract

Neovascularization is critical to destabilization of atheroma. We previously reported that the angiogenic growth factor pleiotrophin (PTN) coaxes monocytes to assume the phenotype of functional endothelial cells in vitro and in vivo. In this study we show that PTN expression is colocalized with capillaries of human atherosclerotic plaques. Among the various reagents that are critical to the pathogenesis of atherosclerosis, interferon (IFN)-gamma was found to markedly induce PTN mRNA expression in a dose-dependent manner in macrophages. Mechanistic studies revealed that the Janus kinase inhibitors, WHI-P154 and ATA, efficiently blocked STAT1 phosphorylation in a concentration- and time-dependent manner. Notably, the level of phosphorylated STAT1 was found to correlate directly with the PTN mRNA levels. In addition, STAT1/STAT3/p44/42 signaling molecules were found to be phosphorylated by IFN-gamma in macrophages, and they were translocated into the nucleus. Further, PTN promoter analysis showed that a gamma-activated sequence (GAS) located at -2086 to -2078 bp is essential for IFN-gamma-regulated promoter activity. Moreover, electrophoretic mobility shift, supershift, and chromatin immunoprecipitation analyses revealed that both STAT1 and STAT3 bind to the GAS at the chromatin level in the IFN-gamma stimulated cells. Finally, to test whether the combined effect of STAT1/STAT3/p44/42 signaling is required for the expression of PTN in macrophages, gene knockdowns of these transcription factors were performed using siRNA. Cells lacking STAT1, but not STAT3 or p42, have markedly reduced PTN mRNA levels. These data suggest that PTN expression in the human plaques may be in part regulated by IFN-gamma and that PTN is involved in the adaptive immunity.-Li, F., Tian, F., Wang, L., Williamson, I. K., Sharifi, B. G., Shah, P. K. Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-gamma/JAK/STAT1 signaling is critical for the expression of PTN in macrophages.

Indexed as

AnimalsAtherosclerosisBlotting, WesternCarrier ProteinsCell Line, TumorCells, CulturedChromatin ImmunoprecipitationCytokinesElectrophoretic Mobility Shift AssayFluorescent Antibody TechniqueHumansImmunohistochemistryInterferon-gammaJanus KinasesMacrophages, PeritonealMiceCarrier ProteinsCytokinesInterferon-gammaJanus KinasesMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3pleiotrophinRNA, Small InterferingSTAT1 Transcription FactorSTAT3 Transcription Factor

Identifiers

PMID19917672
PMCPMC2830133
OpenAlexW2020259235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.